Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
Postdoc in Generative Machine Learning for Biomedical Data | Human Technopole, Milan Build the science that shapes the future of human health. Application closing date: 21.02.2026 Join a place where
-
entrepreneurs, the Ellison Institute of Technology aims to develop and deploy commercially sustainable solutions to solve some of humanity’s most enduring challenges. Our work is guided by four Humane Endeavours
-
of human diseases (e.g., Zhang et al., Nature Microbiology, 2025; Li et al., Nature Metabolism, 2024; Ni et al., Cell Metabolism, 2023; Leung et al., Science Translational Medicine, 2022; Seelbinder et al
-
The Department of Medical Biosciences, Umeå University, Sweden, is offering a postdoctoral scholarship within the project “Developing computational tools for large-scale human intracellular
-
to create a space where scientific discovery in cancer research is transformed into benefits for human health. In collaboration with the Department of Molecular Human Genetics at Heidelberg University
-
Center for Advancement of Blood Cancer Therapies (CABCT) (https://icahn.mssm.edu/research/cabct ). The successful candidate will work on projects involving human induced pluripotent stem cells (iPSCs) and
-
Job Description The Klco lab is looking for a post-doctoral fellow interested in using mouse and human models to understand pediatric AML and MDS. We are part of the Department of Pathology and the
-
degree (PhD or equivalent) in the life sciences (e.g. Biology, Molecular Biology, Biomedicine, (Bio-) Chemistry or similar) Strong interest in human genetics, bioinformatics, research and development in a
-
Three-Year Postdoc Opportunity in Ecosystem Structure, Functions and Services in Offshore Marine ...
environmental challenges linked to the balance between human activities and protection levels of the North Sea and Wadden Sea, our demonstration site located in Denmark. Candidate Profile: We are looking for a
-
progression. Using murine and humanized models, human patient samples, single-cell multiomics (CITE-seq), advanced flow cytometry, proteomics, and mechanistic studies, we aim to identify therapeutic targets